Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Paclitaxel-albumin and S-1 for Advanced Gastric Cancer
NCT04258657Phase 2Unknown
- Sponsor
- Beijing Friendship Hospital
- Start
- Mar 2020
- Primary completion
- Dec 2022
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel, tegafur in gastric cancer (GC), sponsored by Beijing Friendship Hospital. Status: unknown.
02
Drugs
nab-paclitaxeltegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT04258657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04258657.